The efficacy and safety of Tirzepatide for type 2 diabetes subjects with chronic kidney disease: prospective observational study - Trial UMIN000051344
Access comprehensive clinical trial information for UMIN000051344 through Pure Global AI's free database. This phase not specified trial is sponsored by Kushiro Red Cross Hospital and is currently Enrolling by invitation. The study focuses on Type 2 diabetes.
This page provides complete trial specifications, intervention details, outcomes, and location information. Pure Global AI offers free access to University Hospital Medical Information Network data, helping medical device and pharmaceutical companies navigate clinical research efficiently.
Free Database
Powered by Pure Global AI
840K+ Trials
UMIN000051344
Enrolling by invitation
Trial Details
University Hospital Medical Information Network โข UMIN000051344
The efficacy and safety of Tirzepatide for type 2 diabetes subjects with chronic kidney disease: prospective observational study
Study Focus
Observational
Sponsor & Location
Kushiro Red Cross Hospital
Japan
Timeline & Enrollment
N/A
Jun 05, 2023
N/A
ICD-10 Classifications
Type 2 diabetes mellitus
Type 2 diabetes mellitus without complications
Type 2 diabetes mellitus with unspecified complications
Type 2 diabetes mellitus with other specified complications
Type 2 diabetes mellitus with multiple complications
Data Source
University Hospital Medical Information Network
UMIN000051344
Non-Device Trial

